Brief Research Report
Published on 13 Mar 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1484182
Type at least 3 characters
1,840 articles
Articles
Review
Published on 13 Mar 2025
Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1516977
- 122 views
Original Research
Accepted on 12 Mar 2025
Identification of MAD2L1 as a Novel Biomarker for Hepatoblastoma through Bioinformatics and Machine Learning Approaches
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1524714
Review
Accepted on 12 Mar 2025
The role and regulatory mechanism of lysosome associated protein transmembrane 4β(LAPTM4B) in tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1552007
Review
Published on 11 Mar 2025
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1415820
- 187 views
Systematic Review
Accepted on 10 Mar 2025
Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1552914
Case Report
Accepted on 10 Mar 2025
Case Report: Personalized Diagnosis and Treatment Strategies for Three Cases of Cancer of Unknown Primary Based on Molecular Testing Techniques
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1505271
Brief Research Report
Accepted on 10 Mar 2025
Identifying Antisense Oligonucleotides for Targeted Inhibition of Insulin Receptor Isoform A
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1563985
Original Research
Published on 07 Mar 2025
Prognostic value of CA125 in diffuse large B-cell lymphoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1548399
- 579 views
Original Research
Accepted on 05 Mar 2025
A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1511564
Editorial
Published on 05 Mar 2025
Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571403
- 191 views
Retraction
Published on 04 Mar 2025
Retraction: Corrigendum: Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/b-catenin signaling pathway activation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1575643
- 122 views
Review
Accepted on 03 Mar 2025
Profiles of surface markers and chemokines of tumor-associated macrophages in esophageal squamous cell carcinoma: A comprehensive review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1547484
Original Research
Accepted on 03 Mar 2025
Combination of MLo-1508 with Sunitinib for the experimental treatment of papillary Renal Cell Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1399956
Mini Review
Published on 03 Mar 2025
From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1565872
- 625 views
Original Research
Published on 03 Mar 2025
Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1554242
- 152 views